Oxford BioTherapeutics partners with Seattle Genetics to discover and develop antibody-drug conjugates (ADC) to treat cancer

Oxford BioTherapeutics Ltd.

U.K. / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Seattle Genetics Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$2,083.8m on 09/16/2011 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced